MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $885,000 | -8.7% | 5,000 | -16.7% | 0.12% | -12.4% |
| Q2 2021 | $969,000 | -33.4% | 6,000 | -29.4% | 0.14% | -51.6% |
| Q1 2021 | $1,456,000 | +120.9% | 8,500 | +183.3% | 0.28% | +124.6% |
| Q4 2020 | $659,000 | -28.4% | 3,000 | -98.8% | 0.13% | +110.0% |
| Q2 2017 | $921,000 | -29.1% | 255,100 | +2.1% | 0.06% | -14.3% |
| Q1 2017 | $1,299,000 | +174.1% | 249,735 | +150.4% | 0.07% | +150.0% |
| Q4 2016 | $474,000 | -28.1% | 99,735 | 0.0% | 0.03% | +12.0% |
| Q3 2016 | $659,000 | -45.4% | 99,735 | +76.8% | 0.02% | -58.3% |
| Q1 2016 | $1,207,000 | +46.8% | 56,400 | +116.7% | 0.06% | +33.3% |
| Q4 2015 | $822,000 | -60.2% | 26,027 | -56.6% | 0.04% | -47.1% |
| Q3 2015 | $2,065,000 | +917.2% | 60,000 | +391.3% | 0.08% | +553.8% |
| Q4 2013 | $203,000 | – | 12,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |